आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - cimetidine - tablets - 200 milligram

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - cimetidine - tablets - 400 milligram

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - cimetidine - tablets - 800 milligram

यूनाइटेड किंगडम - अंग्रेज़ी - VMD (Veterinary Medicines Directorate)

vetoquinol sa - cimicoxib - chewable tablet - anti inflammatory nsaid - dogs

यूनाइटेड किंगडम - अंग्रेज़ी - VMD (Veterinary Medicines Directorate)

vetoquinol sa - cimicoxib - chewable tablet - anti inflammatory nsaid - dogs

यूनाइटेड किंगडम - अंग्रेज़ी - VMD (Veterinary Medicines Directorate)

vetoquinol sa - cimicoxib - chewable tablet - anti inflammatory nsaid - dogs

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hong kong ban kah chai med. fty. sdn. bhd. - cortex eucommiae; tea leave; spica prunellae; senna fruit powder; rhizoma atractylodis; radix glycyrrhizae extract; radix et rhizoma rhei; pericarpium citri reticulatae; herba menthae; herba dendrobii -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; trometamol; calteridol calcium - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of ge for enhancement of magnetic images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.